Ionis Pharmaceuticals
IONS
IONS
346 hedge funds and large institutions have $4.58B invested in Ionis Pharmaceuticals in 2022 Q2 according to their latest regulatory filings, with 52 funds opening new positions, 89 increasing their positions, 127 reducing their positions, and 31 closing their positions.
New
Increased
Maintained
Reduced
Closed
more call options, than puts
Call options by funds: $ | Put options by funds: $
more first-time investments, than exits
New positions opened: | Existing positions closed:
more funds holding
Funds holding: →
more funds holding in top 10
Funds holding in top 10: →
0.37% less ownership
Funds ownership: 88.19% → 87.82% (-0.37%)
1% less capital invested
Capital invested by funds: $4.62B → $4.58B (-$41.9M)
30% less repeat investments, than reductions
Existing positions increased: 89 | Existing positions reduced: 127
Holders
346
Holding in Top 10
4
Calls
$22.6M
Puts
$8.88M
Top Buyers
| 1 | +$47.3M | |
| 2 | +$26.1M | |
| 3 | +$17.8M | |
| 4 |
BlackRock
New York
|
+$14.3M |
| 5 |
Norges Bank
Oslo,
Norway
|
+$12.3M |
Top Sellers
| 1 | -$53.7M | |
| 2 | -$37.1M | |
| 3 | -$28.3M | |
| 4 |
ClearBridge Investments
New York
|
-$17.4M |
| 5 |
CCM
Camber Capital Management
Boston,
Massachusetts
|
-$11.1M |